Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -0.07% | +269.92% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mahmood Ladha
PSD | President | 60 | 19-11-11 |
Lee F. Allen
CTO | Chief Tech/Sci/R&D Officer | 72 | 17-03-31 |
Marc Banjak
LAW | General Counsel | - | - |
Bill L. Nichols
SAM | Sales & Marketing | - | 18-02-14 |
Stephen Crane
SAM | Sales & Marketing | - | - |
Caroline Diaz
LAW | General Counsel | - | - |
Corporate Secretary | 49 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Henrik Stenqvist
BRD | Director/Board Member | 57 | 19-11-11 |
Guido Oelkers
BRD | Director/Board Member | 59 | 19-11-11 |
Director/Board Member | 55 | 19-11-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,821,405 | 13,851,527 ( 48.06 %) | 0 | 48.06 % |
Company contact information
Dova Pharmaceuticals, Inc.
240 Leigh Farm Road Suite 245
27707, Durham
+919-748-5975
http://www.dova.comSector
1st Jan change | Capi. | |
---|---|---|
+269.92% | 808M | |
+13.69% | 118B | |
+12.96% | 106B | |
-2.74% | 24.28B | |
+0.84% | 21.96B | |
-9.37% | 18.16B | |
-42.12% | 16.37B | |
-17.74% | 15.56B | |
+4.94% | 13.63B | |
+31.64% | 12.27B |
- Stock Market
- Equities
- DOVA Stock
- Company Dova Pharmaceuticals, Inc.